Key result
K2P channel remodeling emerges as a potential therapeutic target in AF and heart failure.
Why the study?
Alterations in K2P-channel expression and function in cardiovascular diseases suggest functional significance and therapeutic potential, but functional evidence for several channels in cardiac tissue remains sparse.
Answers are grounded in this paper and cite their sources.
K2P channels are emerging as significant modulators of cardiac electrophysiology and represent promising novel targets for the treatment of atrial fibrillation and other cardiovascular diseases.
Two-pore-domain potassium (K2P-) channels conduct outward K+ currents that maintain the resting membrane potential and modulate action potential repolarization. Members of the K2P channel family are widely expressed among different human cell types and organs where they were shown to regulate important physiological processes. Their functional activity is controlled by a broad variety of different stimuli, like pH level, temperature, and mechanical stress but also by the presence of lipids or pharmacological agents. In patients suffering from cardiovascular diseases, alterations in K2P-channel expression and function have been observed, suggesting functional significance and a potential therapeutic role of these ion channels. For example, upregulation of atrial specific K2P3.1 (TASK-1) currents in atrial fibrillation (AF) patients was shown to contribute to atrial action potential duration shortening, a key feature of AF-associated atrial electrical remodelling. Therefore, targeting K2P3.1 (TASK-1) channels might constitute an intriguing strategy for AF treatment. Further, mechanoactive K2P2.1 (TREK-1) currents have been implicated in the development of cardiac hypertrophy, cardiac fibrosis and heart failure. Cardiovascular expression of other K2P channels has been described, functional evidence in cardiac tissue however remains sparse. In the present review, expression, function, and regulation of cardiovascular K2P channels are summarized and compared among different species. Remodelling patterns, observed in disease models are discussed and compared to findings from clinical patients to assess the therapeutic potential of K2P channels.
No takes yet. Share an insight, caveat, or question.
Wiedmann et al. (2021) conducted a review in Cardiovascular diseases (Atrial fibrillation, heart failure, hypertrophy). K2P channels (e.g., TASK-1, TREK-1) was evaluated. K2P channels, particularly TASK-1 and TREK-1, undergo disease-specific remodeling in cardiovascular conditions such as atrial fibrillation and heart failure, presenting potential therapeutic targets.
Synapse has enriched 10 related papers. Consider them for comparative context: